ono 1078 has been researched along with Alveolitis, Fibrosing in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pranlukast attenuates the progression of pulmonary fibrosis in the chronic phase but has no effect on the acute inflammatory response or on the onset of pulmonary fibrosis." | 1.38 | Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice. ( Okunishi, H; Shimbori, C; Shiota, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fireman, E | 1 |
| Shimbori, C | 1 |
| Shiota, N | 1 |
| Okunishi, H | 1 |
2 other studies available for ono 1078 and Alveolitis, Fibrosing
| Article | Year |
|---|---|
A silica-induced pulmonary fibrosis model: are we closer to 'real life'?
Topics: Animals; Chromones; Female; Leukotriene Antagonists; Pulmonary Fibrosis; Silicon Dioxide | 2012 |
Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chromones; Cytokines; Disease Progression; Female; Hydroxypro | 2012 |